Home Reimbursed medicines Methylfenidat
Methylfenidat — maximum prices and reimbursement
The CANAMED catalogue contains 22 medicines with the active substance Methylfenidat, from 2 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Methylfenidat there are 22 authorised medicines in the CANAMED catalogue, with maximum retail prices between 59.12 and 140.50 RON, from 2 manufacturers. The reimbursement percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price, not to the shelf price. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Methylfenidat
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| CONCERTA 18 mg | JANSSEN PHARMACEUTICA N.V. - BELGIA | 59.12 RON | C3 (children, pupils, pregnant women) | PS |
| CONCERTA 36 mg | JANSSEN PHARMACEUTICA N.V. - BELGIA | 98.80 RON | C3 (children, pupils, pregnant women) | PS |
| CONCERTA 54 mg | JANSSEN PHARMACEUTICA N.V. - BELGIA | 140.50 RON | C3 (children, pupils, pregnant women) | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 54 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 54 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 54 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CLORHIDRAT DE METILFENIDAT G.L. PHARMA 54 mg | LABORATORIOS LICONSA S.A. - SPANIA | — | not reimbursed | PS |
| CONCERTA 18 mg | JANSSEN PHARMACEUTICA N.V. - BELGIA | — | not reimbursed | PS |
| CONCERTA 36 mg | JANSSEN PHARMACEUTICA N.V. - BELGIA | — | not reimbursed | PS |
| CONCERTA 54 mg | JANSSEN PHARMACEUTICA N.V. - BELGIA | — | not reimbursed | PS |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PS — With a medical prescription, started/used in hospital (P-S)
This catalogue does not record the reimbursement percentage per product. Reimbursement is set through the CNAS sublists — A 90%, B 50%, C1/C2 100%, D 20% of the reference price — see the full explanation of the sublists or ask the pharmacist for the exact placement.
Live pharmacy prices
Products with Methylfenidat in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 18 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 27 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg
- CLORHIDRAT DE METILFENIDAT G.L. PHARMA 36 mg
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Metformin
- Memantin
- Metoprolol
- Montelukast
- Midazolam
- Methotrexat
- Moxifloxacin
- Metamizol natri
- Meropenem
- Mirabegron
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Methylfenidat
-
Is Methylfenidat reimbursed?
Reimbursement for Methylfenidat depends on the CNAS sublist the prescribed product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and on the reference price of the therapeutic group — not on the shelf price. The electronic prescription automatically shows the sublist and your contribution; ask the doctor or pharmacist for your exact situation. -
What is the CANAMED maximum price for Methylfenidat?
The maximum retail prices (the CANAMED legal cap) for medicines with Methylfenidat are between 59.12 and 140.50 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Methylfenidat is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Methylfenidat are in the CANAMED catalogue?
The CANAMED catalogue holds 22 authorised medicines with the active substance Methylfenidat — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go